MECHANISMS WHEREBY CD4 T CELLS ACTIVATE AMI AND CMI

CD4 T 细胞激活 AMI 和 CMI 的机制

基本信息

项目摘要

Despite many years of intensive effort to conquer malaria, it remains a leading cause of death due to an infectious disease. The recent advent of drug-resistant malarial parasites and the development of insecticide resistance by the mosquito vector jointly make the development of immune-based therapy or prophylaxis highly desirable. To do so, requires a detailed understanding of the immune response to malarial antigens. CD4+ T cells are believed to be essential for the resolution of bloodstage malaria (the stage examined in this proposal), but little is known about how CD4+ T cells actually influence protective effector mechanisms. Resolution of acute infections caused by different rodent species of Plasmodium appear to use distinct mechanisms of resolution, with P. yoelii being suppressed by antibody-mediated immunity (AMI) and P. chabaudi by cell-mediated immunity. Our goal is to use these species of Plasmodium to elucidate the molecular mechanisms whereby CD4+ T cells, by differentiating into distinct Th cell-phenotypes, regulate B cell and macrophage function during malaria. To address this goal, we intend to first examine in detail Th cell-differentiation and its requirement for resolution of infection. These findings will be incorporated into subsequent studies aimed at identifying how Th cell- differentiation affects selected parameters of protective antibody development and macrophage function during malaria. We will also address the question of whether antibodies augment macrophage function in vivo to clear parasites from blood. The results of these studies will aid in the design of future experiments crucial to our understanding of protective immune mechanisms responsible for the resolution of malaria in humans.
尽管多年来为征服疟疾作出了大量努力,但它仍然是一个严重的疾病

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HENRI C VAN DER HEYDE其他文献

HENRI C VAN DER HEYDE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HENRI C VAN DER HEYDE', 18)}}的其他基金

Novel nanoparticles function as chemo- and adjunctive-therapy against experimental cerebral malaria
新型纳米颗粒可作为实验性脑型疟疾的化疗和辅助疗法
  • 批准号:
    10308498
  • 财政年份:
    2020
  • 资助金额:
    $ 17.99万
  • 项目类别:
Role of platelet CD40 in experimental cerebral malaria coagulopathy
血小板 CD40 在实验性脑型疟疾凝血病中的作用
  • 批准号:
    8035475
  • 财政年份:
    2010
  • 资助金额:
    $ 17.99万
  • 项目类别:
Citrulline adjunctive therapy for cerebral malaria
瓜氨酸辅助治疗脑型疟疾
  • 批准号:
    8089237
  • 财政年份:
    2010
  • 资助金额:
    $ 17.99万
  • 项目类别:
Role of platelet CD40 in experimental cerebral malaria coagulopathy
血小板 CD40 在实验性脑型疟疾凝血病中的作用
  • 批准号:
    7880276
  • 财政年份:
    2010
  • 资助金额:
    $ 17.99万
  • 项目类别:
Citrulline adjunctive therapy for cerebral malaria
瓜氨酸辅助治疗脑型疟疾
  • 批准号:
    7898993
  • 财政年份:
    2010
  • 资助金额:
    $ 17.99万
  • 项目类别:
ABI-PRISM 7700 TO ASSESS MRNA AND DNA
ABI-PRISM 7700 用于评估 mRNA 和 DNA
  • 批准号:
    2805356
  • 财政年份:
    1999
  • 资助金额:
    $ 17.99万
  • 项目类别:
MECHANISMS WHEREBY CD4 T CELLS ACTIVATE AMI AND CMI
CD4 T 细胞激活 AMI 和 CMI 的机制
  • 批准号:
    6169768
  • 财政年份:
    1997
  • 资助金额:
    $ 17.99万
  • 项目类别:
MECHANISMS WHEREBY CD4 T CELLS ACTIVATE AMI AND CMI
CD4 T 细胞激活 AMI 和 CMI 的机制
  • 批准号:
    2887355
  • 财政年份:
    1997
  • 资助金额:
    $ 17.99万
  • 项目类别:
Cell adhesion molecules in cerebral malaria.
脑型疟疾中的细胞粘附分子。
  • 批准号:
    6935256
  • 财政年份:
    1997
  • 资助金额:
    $ 17.99万
  • 项目类别:
Cell adhesion molecules in cerebral malaria.
脑型疟疾中的细胞粘附分子。
  • 批准号:
    6690987
  • 财政年份:
    1997
  • 资助金额:
    $ 17.99万
  • 项目类别:

相似海外基金

Meiosis in Plasmodium: How does it work?
疟原虫减数分裂:它是如何运作的?
  • 批准号:
    BB/X014681/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.99万
  • 项目类别:
    Research Grant
Meiosis in Plasmodium: How does it work?
疟原虫减数分裂:它是如何运作的?
  • 批准号:
    BB/X014452/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.99万
  • 项目类别:
    Research Grant
Genomics and sero-epidemiology of Plasmodium falciparum malaria in a pre-elimination setting
消灭前环境中恶性疟原虫疟疾的基因组学和血清流行病学
  • 批准号:
    10666280
  • 财政年份:
    2023
  • 资助金额:
    $ 17.99万
  • 项目类别:
Chemical Biology Strategies to Resolve Plasmodium Heat Shock Protein Function
解决疟原虫热休克蛋白功能的化学生物学策略
  • 批准号:
    10734886
  • 财政年份:
    2023
  • 资助金额:
    $ 17.99万
  • 项目类别:
Exocytosis of Plasmodium egress and invasion organelles
疟原虫出口和入侵细胞器的胞吐作用
  • 批准号:
    10888455
  • 财政年份:
    2023
  • 资助金额:
    $ 17.99万
  • 项目类别:
Comprehensive characterization of the genetic factors and the host immune response associated to protection from clinical Plasmodium vivax malaria
与预防临床间日疟原虫疟疾相关的遗传因素和宿主免疫反应的综合特征
  • 批准号:
    10634775
  • 财政年份:
    2023
  • 资助金额:
    $ 17.99万
  • 项目类别:
Developing inhibitors of Plasmodium Acetyl CoA Synthetase as new multistage antimalarials
开发疟原虫乙酰辅酶A合成酶抑制剂作为新型多级抗疟药
  • 批准号:
    MR/X030202/1
  • 财政年份:
    2023
  • 资助金额:
    $ 17.99万
  • 项目类别:
    Research Grant
Optimising a High Efficacy Plasmodium vivax Malaria Vaccine (OptiViVax)
优化高效间日疟原虫疟疾疫苗 (OptiViVax)
  • 批准号:
    10079676
  • 财政年份:
    2023
  • 资助金额:
    $ 17.99万
  • 项目类别:
    EU-Funded
Extent, dynamics and mechanisms of Plasmodium vivax immune evasion caused by PvDBP gene amplification
PvDBP基因扩增引起间日疟原虫免疫逃避的程度、动态及机制
  • 批准号:
    10734028
  • 财政年份:
    2023
  • 资助金额:
    $ 17.99万
  • 项目类别:
Parasite and host cell factors involved in the formation and persistence of Plasmodium vivax hypnozoites
寄生虫和宿主细胞因子参与间日疟原虫休眠子的形成和持续存在
  • 批准号:
    10564073
  • 财政年份:
    2023
  • 资助金额:
    $ 17.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了